Home LiteratureArticle Details
PMID: 20826734 Published · ppublish English Editorial Comment

The hazards of endpoints.

Journal of the National Cancer Institute ·Vol. 102 ·No. 18 ·2010-09-22 ·Pages 1376-7

Berry DA

Abstract

暂无摘要

MeSH Terms
Biomarkers, Tumor/metabolism Clinical Trials as Topic/standards,trends Humans Immunity, Cellular Immunotherapy/methods,standards,trends Kaplan-Meier Estimate Models, Statistical Neoplasms/immunology,therapy Outcome Assessment, Health Care Randomized Controlled Trials as Topic/standards Time Factors Treatment Outcome
Chemicals
Biomarkers, Tumor
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Berry Donald A
Article Info
Journal
Journal of the National Cancer Institute
Abbr.
J Natl Cancer Inst
ISSN
1460-2105
Published
2010-09-22
Epub
2010-00-08
Pages
1376-7
Language
English
Region
United States
NLM ID
7503089
Subset
IM
Corrections
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]